NO831873L - Fremgangsmaate for fremstilling av nye alkan- og alkenderivater - Google Patents
Fremgangsmaate for fremstilling av nye alkan- og alkenderivaterInfo
- Publication number
- NO831873L NO831873L NO831873A NO831873A NO831873L NO 831873 L NO831873 L NO 831873L NO 831873 A NO831873 A NO 831873A NO 831873 A NO831873 A NO 831873A NO 831873 L NO831873 L NO 831873L
- Authority
- NO
- Norway
- Prior art keywords
- alkender
- alkan
- derivatives
- procedure
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/09—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis
- C07C29/095—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis of esters of organic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/09—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis
- C07C29/10—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis of ethers, including cyclic ethers, e.g. oxiranes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/128—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by alcoholysis
- C07C29/1285—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by alcoholysis of esters of organic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/26—Polyhydroxylic alcohols containing only six-membered aromatic rings as cyclic part
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/28—Alcohols containing only six-membered aromatic rings as cyclic part with unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/205—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings
- C07C39/21—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings with at least one hydroxy group on a non-condensed ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/24—Halogenated derivatives
- C07C39/367—Halogenated derivatives polycyclic non-condensed, containing only six-membered aromatic rings as cyclic parts, e.g. halogenated poly-hydroxyphenylalkanes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/24—Halogenated derivatives
- C07C39/373—Halogenated derivatives with all hydroxy groups on non-condensed rings and with unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/14—Unsaturated ethers
- C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
- C07C43/1782—Unsaturated ethers containing hydroxy or O-metal groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/12—Acetic acid esters
- C07C69/14—Acetic acid esters of monohydroxylic compounds
- C07C69/145—Acetic acid esters of monohydroxylic compounds of unsaturated alcohols
- C07C69/157—Acetic acid esters of monohydroxylic compounds of unsaturated alcohols containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/12—Acetic acid esters
- C07C69/16—Acetic acid esters of dihydroxylic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/78—Benzoic acid esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/06—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Furan Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrane Compounds (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI821879A FI67538C (fi) | 1982-05-27 | 1982-05-27 | Foerfarande foer framstaellning av (z)-1,2-difenyl-1-(4-(2-(n n-dimetylamino)etoxi)fenyl)-1-buten |
GB08218414A GB2126576B (en) | 1982-06-25 | 1982-06-25 | Alkane and alkene derivatives |
Publications (3)
Publication Number | Publication Date |
---|---|
NO831873L true NO831873L (no) | 1983-11-28 |
NO156164B NO156164B (no) | 1987-04-27 |
NO156164C NO156164C (no) | 1987-08-05 |
Family
ID=26157340
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO831873A NO156164C (no) | 1982-05-27 | 1983-05-26 | Analogifremgangsmaate for fremstilling av nye terapeutisk aktive alkan- og alkenderivater. |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0095875B1 (no) |
JP (3) | JPH037239A (no) |
AU (1) | AU556608B2 (no) |
BG (1) | BG60760B2 (no) |
CA (1) | CA1185977A (no) |
DD (1) | DD230864A1 (no) |
DE (1) | DE3366021D1 (no) |
DK (1) | DK170927B1 (no) |
FI (1) | FI77839C (no) |
IE (1) | IE55023B1 (no) |
IL (1) | IL68784A (no) |
LU (1) | LU88803I2 (no) |
NL (1) | NL960021I2 (no) |
NO (1) | NO156164C (no) |
NZ (1) | NZ204349A (no) |
SG (1) | SG65488G (no) |
SU (1) | SU1508955A3 (no) |
UA (1) | UA5558A1 (no) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK368687A (da) * | 1986-11-21 | 1988-05-22 | Cheminova As | Aminoalkylerede hydroxyforbindelser og deres anvendelse som fungicider |
DE3722807A1 (de) * | 1987-07-10 | 1989-01-19 | Hoechst Ag | Neue 3,5-dihydroxycarbonsaeuren und deren derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte |
CA2092996A1 (en) * | 1990-10-01 | 1992-04-02 | David Yang | High affinity tamoxifen derivatives and uses thereof |
US5811447A (en) | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
GB9207437D0 (en) * | 1992-04-03 | 1992-05-20 | Orion Yhtymae Oy | Topical administration of toremifene and its metabolites |
DE4212628A1 (de) * | 1992-04-15 | 1993-10-21 | Manfred Dr Metzler | Neue Bis-phenyl-hexene |
US6251920B1 (en) | 1993-05-13 | 2001-06-26 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies |
US5770609A (en) | 1993-01-28 | 1998-06-23 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies |
US6491938B2 (en) | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
DE69435137D1 (de) | 1993-05-13 | 2008-10-16 | Poniard Pharmaceuticals Inc | Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind |
US6197789B1 (en) | 1995-06-07 | 2001-03-06 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
US5681835A (en) * | 1994-04-25 | 1997-10-28 | Glaxo Wellcome Inc. | Non-steroidal ligands for the estrogen receptor |
WO1998046588A2 (en) | 1997-04-11 | 1998-10-22 | Neorx Corporation | Compounds and therapies for the prevention of vascular and non-vascular pathologies |
CA2301032C (en) | 1997-08-15 | 2009-01-13 | Duke University | A method of preventing or treating estrogen-dependent diseases and disorders |
DE1003496T1 (de) * | 1998-05-07 | 2000-11-02 | Univ Tennessee Res Corp | Methode zur Vorbeugung von Prostatakrebs |
US6413533B1 (en) | 1998-05-07 | 2002-07-02 | The University Of Tennessee Research Corporation | Method for chemoprevention of prostate cancer |
US6632447B1 (en) | 1998-05-07 | 2003-10-14 | The University Of Tennessee Research Corporation | Method for chemoprevention of prostate cancer |
AU2003203589B2 (en) * | 1998-05-07 | 2005-10-27 | The University Of Tennessee Research Corporation | A method for chemoprevention of prostate cancer |
US6413535B1 (en) | 1998-05-07 | 2002-07-02 | The University Of Tennessee Research Corporation | Method for chemoprevention of prostate cancer |
US6833373B1 (en) | 1998-12-23 | 2004-12-21 | G.D. Searle & Co. | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
US6858598B1 (en) | 1998-12-23 | 2005-02-22 | G. D. Searle & Co. | Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
SI1235776T1 (sl) * | 1999-11-16 | 2006-06-30 | Hormos Medical Corp | Trifenilalkenski derivati in njihova uporaba kot selektivni estrogenski receptorski modulatorji |
TW593256B (en) * | 1999-11-16 | 2004-06-21 | Hormos Medical Oy Ltd | Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
FI111710B (fi) | 2001-05-04 | 2003-09-15 | Hormos Medical Oy Ltd | Menetelmä terapeuttisesti aktiivisen yhdisteen valmistamiseksi |
FI20030747A0 (fi) | 2003-05-19 | 2003-05-19 | Orion Corp | Toremifeenin kiteytysmenetelmä |
US20040248989A1 (en) | 2003-06-05 | 2004-12-09 | Risto Santti | Method for the treatment or prevention of lower urinary tract symptoms |
CN101448490A (zh) | 2006-05-22 | 2009-06-03 | 霍尔莫斯医疗有限公司 | 治疗慢性非细菌性前列腺炎的选择性雌激素受体调节剂或者芳香酶抑制剂 |
US7504530B2 (en) | 2007-02-14 | 2009-03-17 | Hormos Medical Ltd. | Methods for the preparation of fispemifene from ospemifene |
EP2121553B1 (en) | 2007-02-14 | 2012-06-27 | Hormos Medical Ltd. | Method for the preparation of therapeutically valuable triphenylbutene derivatives |
FI121626B (fi) * | 2009-01-29 | 2011-02-15 | Stora Enso Oyj | Menetelmä olefiinisten monomeerien tuottamiseksi |
JP6174156B2 (ja) | 2012-10-19 | 2017-08-02 | フェルミオン オサケ ユキチュア | オスペミフェンの製造方法 |
KR101819639B1 (ko) * | 2016-06-27 | 2018-01-17 | 주식회사 케미메디 | 신규한 아릴에텐 유도체 및 이를 유효성분으로 함유하는 약제학적 조성물 |
-
1983
- 1983-05-09 FI FI831584A patent/FI77839C/fi not_active IP Right Cessation
- 1983-05-20 LU LU88803C patent/LU88803I2/fr unknown
- 1983-05-20 DE DE8383302912T patent/DE3366021D1/de not_active Expired
- 1983-05-20 CA CA000428668A patent/CA1185977A/en not_active Expired
- 1983-05-20 EP EP83302912A patent/EP0095875B1/en not_active Expired
- 1983-05-24 DD DD83251216A patent/DD230864A1/de not_active IP Right Cessation
- 1983-05-25 IL IL68784A patent/IL68784A/xx not_active IP Right Cessation
- 1983-05-25 AU AU14946/83A patent/AU556608B2/en not_active Expired
- 1983-05-25 NZ NZ204349A patent/NZ204349A/en unknown
- 1983-05-26 DK DK236583A patent/DK170927B1/da not_active IP Right Cessation
- 1983-05-26 SU SU833597902A patent/SU1508955A3/ru active
- 1983-05-26 IE IE1247/83A patent/IE55023B1/en not_active IP Right Cessation
- 1983-05-26 UA UA3597902A patent/UA5558A1/uk unknown
- 1983-05-26 NO NO831873A patent/NO156164C/no not_active IP Right Cessation
-
1988
- 1988-09-30 SG SG654/88A patent/SG65488G/en unknown
-
1990
- 1990-04-26 JP JP2114935A patent/JPH037239A/ja active Granted
-
1992
- 1992-10-27 JP JP4289137A patent/JPH0678257B2/ja not_active Expired - Lifetime
- 1992-10-27 JP JP4289136A patent/JPH0742241B2/ja not_active Expired - Lifetime
-
1994
- 1994-01-18 BG BG098379A patent/BG60760B2/bg unknown
-
1996
- 1996-08-14 NL NL960021C patent/NL960021I2/nl unknown
Also Published As
Publication number | Publication date |
---|---|
JPH037239A (ja) | 1991-01-14 |
AU556608B2 (en) | 1986-11-13 |
NL960021I1 (nl) | 1996-11-01 |
IL68784A0 (en) | 1983-09-30 |
CA1185977A (en) | 1985-04-23 |
BG60760B2 (bg) | 1996-02-29 |
DK170927B1 (da) | 1996-03-18 |
JPH0656724A (ja) | 1994-03-01 |
NO156164C (no) | 1987-08-05 |
FI831584A0 (fi) | 1983-05-09 |
JPH06100485A (ja) | 1994-04-12 |
FI77839C (fi) | 1989-05-10 |
IE55023B1 (en) | 1990-04-25 |
SG65488G (en) | 1989-06-16 |
JPH0579654B2 (no) | 1993-11-04 |
SU1508955A3 (ru) | 1989-09-15 |
NL960021I2 (nl) | 1997-07-01 |
NZ204349A (en) | 1985-03-20 |
FI831584L (fi) | 1983-11-28 |
DE3366021D1 (en) | 1986-10-16 |
NO156164B (no) | 1987-04-27 |
DK236583A (da) | 1983-11-28 |
DD230864A1 (de) | 1985-12-11 |
UA5558A1 (uk) | 1994-12-28 |
DK236583D0 (da) | 1983-05-26 |
IL68784A (en) | 1986-11-30 |
JPH0742241B2 (ja) | 1995-05-10 |
EP0095875A3 (en) | 1984-07-25 |
IE831247L (en) | 1983-11-27 |
FI77839B (fi) | 1989-01-31 |
LU88803I2 (fr) | 1996-11-05 |
EP0095875A2 (en) | 1983-12-07 |
JPH0678257B2 (ja) | 1994-10-05 |
AU1494683A (en) | 1984-01-19 |
EP0095875B1 (en) | 1986-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO831873L (no) | Fremgangsmaate for fremstilling av nye alkan- og alkenderivater | |
NO811731L (no) | Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater | |
NO813678L (no) | Fremgangsmaate for fremstilling av karbostyrilderivater | |
NO843956L (no) | Fremgangsmaate for fremstilling av karboksyalkenamido-cefalosporiner | |
NO790358L (no) | Fremgangsmaate for fremstilling av alkylendiaminderivater | |
NO831792L (no) | Fremgangsmaate til fremstilling av nye imidazo-pyrazolopyrimidiner | |
NO794317L (no) | Fremgangsmaate for fremstilling av pyrido-indolderivater | |
NO844978L (no) | Fremgangsmaate ved fremstilling av nye aminoguanidinderivater | |
NO845207L (no) | Fremgangsmaate for fremstilling av diaminopolyalkenyletere | |
NO823161L (no) | Fremgangsmaate for fremstilling av aminopropanolderivater | |
NO860857L (no) | Nye oksadiazolyl-imidazobenzodiazepin-derivater og fremgangsmaate for fremstilling av slike forbindelser. | |
NO823637L (no) | Fremgangsmaate for fremstilling av eburnamoninderivater | |
NO844118L (no) | Fremgangsmaate for fremstilling av imidazolinderivater | |
NO150799C (no) | Fremgangsmaate for fremstilling av lysergol-derivater | |
NO833527L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklobutylderivater | |
NO813477L (no) | Fremgangsmaate for fremstilling av karbostyrilderivater | |
NO845148L (no) | Fremgangsmaate for fremstilling av 16-fenoksy- og 16-substituert-fenoksy-prostatrinsyre-derivater | |
SE7802024L (sv) | Forfarande for framstellning av pyrrolokinoxalinoner och pyrrolobensodiazepinoner | |
NO834437L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive spiro-3-hetero-azolon-derivater | |
NO831874L (no) | Fremgangsmaate for fremstilling av trifenylbuten-derivater | |
NO831994L (no) | Fremgangsmaate for fremstilling av pyrimidinon-derivater | |
NO812842L (no) | Fremgangsmaate for fremstilling av aminoacetonitil-derivater | |
NO844072L (no) | Fremgangsmaate for fremstilling av nye aminopropanonforbindelser | |
NO842078L (no) | Fremgangsmaate for fremstilling av nye aryloxycycloalkanol-aminoalkylenarylketoner | |
NO792659L (no) | Fremgangsmaate for fremstilling av karbostyrilderivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |
Free format text: EXPIRED IN MAY 2003 |